Skip to content

Clinical trials

Metabolic Syndrome trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Syndrome Country / region: Belgium Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20081
20151
20191
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting3
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb1
Cliniques universitaires Saint-Luc- Université Catholique de Louvain1
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Julius Clinical1
KU Leuven1
Patrice D. Cani1
Universitaire Ziekenhuizen KU Leuven1
Universiteit Antwerpen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Syndrome9
Obesity3
Diabetes Mellitus, Type 22
Hypertension2
Liver Cirrhosis2
Body Weight1
Bursitis1
Diabetes Mellitus1
Dyslipidemias1
Endocrine System Diseases1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.